Table 3.
Visit questionnaire sample characteristics (N = 1479 visit questionnaires).
| Clinical | n | (%) |
|---|---|---|
| Illness preventing daily activities since last follow-up visit | ||
| No | 1359 | (91.9) |
| Yes | 120 | (8.1) |
| Side effects to Truvada in last 30 days | ||
| No | 1433 | (96.9) |
| Yes | 38 | (2.6) |
| Lifestyle | ||
| Injected drugs since last follow-up visit | ||
| No | 1348 | (91.1) |
| Yes | 130 | (8.8) |
| Snorted cocaine since last follow-up visit | ||
| No | 1182 | (79.9) |
| Yes | 297 | (20.1) |
| Sexual behaviour | ||
| Number of condomless anal sex partners since last follow-up visit | ||
| 0 | 77 | (5.2) |
| 1 | 362 | (24.5) |
| 2–5 | 606 | (41) |
| >6 | 433 | (29.3) |
| Engaged in chemsex since last follow-up visit | ||
| No | 909 | (61.5) |
| Yes | 570 | (38.5) |
| Engaged in group sex since last follow-up visit | ||
| No | 783 | (52.9) |
| Yes | 696 | (47.1) |
| Used sex toys since last follow-up visit | ||
| No | 1124 | (76) |
| Yes | 355 | (24) |
| Engaged in fisting since last follow-up visit | ||
| No | 1273 | (86.1) |
| Yes | 205 | (13.9) |
| Follow-up period prep adherence | ||
| <7/7ID reported within last 90-day period | ||
| No | 1037 | (70.1) |
| Yes | 442 | (29.9) |
Number of follow-up visit questionnaires with missing data for side effects (8); injected drugs(1); number of condomless anal sex partners (1); fisting (1)